Short and Long Term Exposure to Unique, Time-Varying Pulsed Electro-Magnetic Fields in Refractory Carpal Tunnel Syndrome

Completed · Phase 4

Conditions studied: Refractory Carpal Tunnel Syndrome, Neurpathic Pain, Neuromodulaton

In brief

Pulsed electromagnetic fields (PEMF) have been approved by FDA and are utilized currently in treating non-union fractures, neurogenic bladder and musculoskeletal pains. Based on 2 prior pilot studies (open label) demonstrating reduction in neuropathic pain from carpal tunnel syndrome we decided to perform a placebo-controlled trial, randomized for 2 months utilizing a wrist PEMF device attached by Velcro for 4 hours/day.

Key facts

Study ID

NCT00277563

Run by

Weintraub, Michael I., MD, FACP, FAAN

People needed

50

Starts

2004-06-01

Expected to finish

2005-07-01

Last updated by the study team

2007-09-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Intractable neuropathic pain in median nerve innervated hand for at least 3 months;
• Abnormal neurological examination compatible with diagnosis of CTS

You may not qualify if…

• Post-surgical failures,
• Pregnancy,
• Pts with pacemaker

Where it is running

• Michael I. Weintraub MD, PC — Briarcliff, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.